HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Versican, biglycan, and decorin protein expression patterns in coronary arteries: analysis of primary and restenotic lesions.

Abstract
The pathobiology of rapid intimal thickening following balloon angioplasty remains unsettled. Proteoglycans (PGs) expressed by smooth-muscle cells (SMCs) are known to participate in vascular responses to injury. In this analysis, patients ranging from age 48 to 79 years (mean = 58), underwent atherectomy for 36 restenotic tissues (taken 64 to 345 days postangioplasty; mean = 108) and for 10 primary atherosclerotic plaques. Tissues were formaldehyde-fixed, paraffin-embedded, and histochemically and immunohistochemically stained to determine the temporal and semi-quantitative contribution of major vessel wall PGs, versican, biglycan, and decorin. Versican was the most striking PG in the neointima of restenotic vessels, including a prominent pericellular pattern corresponding to proliferative SMCs, as well as a large extracellular accumulation. Biglycan was limited to the most loose and proliferative neointima and stained less than in primary plaques. Decorin staining was virtually absent in the most proliferative neointimal tissue, whereas it was quite striking in established primary lesions. Thus the earliest response to balloon injury of a coronary artery includes striking expression of versican protein, but the limited expression of biglycan differs from the prominence of the PG in primary atherosclerosis. Versican expression in restenotic lesions is similar to that seen previously in transplant arteriopathy, but the lack of biglycan in atherectomy specimens from restenosis sites is distinctively different from that seen in rapidly progressive transplant vascular disease.
AuthorsH Lin, T Kanda, Y Hoshino, S Takase, I Kobayashi, R Nagai, B M McManus
JournalCardiovascular pathology : the official journal of the Society for Cardiovascular Pathology (Cardiovasc Pathol) 1998 Jan-Feb Vol. 7 Issue 1 Pg. 31-7 ISSN: 1054-8807 [Print] United States
PMID25989961 (Publication Type: Journal Article)
CopyrightCopyright © 1998 Elsevier Science Inc. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: